Title : [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].

Pub. Date : 2004 Apr

PMID : 15148932






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since the introduction of the phosphodiesterase type 5 (PDE-5) inhibitor sildenafil in 1998, there has been a fundamental change in the treatment of erectile dysfunction (ED). Sildenafil Citrate phosphodiesterase 5A Homo sapiens
2 Since the introduction of the phosphodiesterase type 5 (PDE-5) inhibitor sildenafil in 1998, there has been a fundamental change in the treatment of erectile dysfunction (ED). Sildenafil Citrate phosphodiesterase 5A Homo sapiens